B2B Pharma Brand Recall vs Prescription Frequency Correlation Survey
Medical representatives, brand managers, and key account leads evaluate, compare, and navigate brand recall strength against prescription conversion rates, so you can sharpen detailing strategy, benchmark brand equity by specialty, and fix gaps in prescriber acquisition.
CONTEXT & RELEVANCE
Why run this survey now
Most pharma brand managers don't lose prescription share purely on clinical efficacy. They lose it due to weak recall at the point of prescribing, fragmented detailing frequency, misaligned messaging by specialty, low share-of-voice in high-volume therapeutic segments, and poor recall-to-script conversion, none of which fully show up in sales force activity reports or CRM call logs.
If you are...
- Pharma brand manager, mature molecule
- Medical affairs head, specialty portfolio
- Sales force effectiveness lead
- Commercial strategy head, Rx growth
- Therapeutic area marketing director
You're likely facing...
- Recall-to-prescription conversion gap
- Detailing frequency vs. script lift mismatch
- Specialty segment recall: cardiologist vs. GP
- Branded generics eroding top-of-mind position
- Message recall drop across rep cycles
This will help answer...
- Recall drivers beyond detailing frequency
- Prescription drop-off by specialty
- Brand vs. molecule recall split
- Optimal contact frequency per segment
- Switching triggers at renewal prescribing
RESEARCH THEMES
What This Survey Investigates
Eight interconnected research themes that map the complete pharma brand journey from physician awareness to repeat prescription behaviour.
Brand Recall Depth
- Unaided vs aided recall rates
- Recall by therapeutic category
Prescription Trigger Points
- First-line vs second-line prescribing triggers
- Patient profile cues driving brand choice
Detailing & Touchpoints
- Medical rep visit frequency and quality
- Digital vs in-person channel preference
Recall vs Rx Gap
- Brands recalled but not prescribed
- Conversion barriers at point of prescribing
Pricing & Formulary
- MRP sensitivity across patient segments
- Formulary listing impact on Rx frequency
Peer & KOL Influence
- KOL endorsement weight in prescribing decisions
- Peer referral patterns across specialties
Clinical Evidence Trust
- Trial data credibility by publication source
- Real-world evidence vs RCT preference
Competitive Brand Positioning
- Head-to-head brand preference by molecule
- Switching triggers toward competitor brands
SAMPLING STRATEGY
Tell us about your ideal sample
Help us understand your target respondent profile. Select what applies, we'll design the optimal sample plan based on your inputs.
METHODOLOGY
Survey approach
For the B2B Pharma Brand Recall vs Prescription Frequency Correlation Survey, we recommend a quant-first design with flexible data-collection modes to balance reach, depth, and verification.
EXECUTION PROCESS
How we execute
A proven 9-step process from scoping to delivery, designed to ensure quality, speed, and actionable insights.
Define the decision frame
Confirm objectives, target cohorts, geographies, and reporting cuts
Define the decision frame
Design the instrument
Build workstream modules mapped to outputs (drivers, friction, pricing, retention, trust)
Design the instrument
Lock the questionnaire
Review wording, sequencing, LOI, and competitive context; approve final version
Lock the questionnaire
Pilot and calibrate
Test comprehension and ease quality; refine quotas and remove friction where needed
Pilot and calibrate
Run fieldwork
Execute collection with active quota management and feasibility controls
Run fieldwork
Assure quality
Dedupe, attention checks, speed/consistency rules, removals with audit trail
Assure quality
Prepare the dataset
Clean data and deliver codebook/variable definitions
Prepare the dataset
Analyse and synthesise
Driver ranking, leakage diagnostics, pricing bands, segment insights
Analyse and synthesise
Deliver and align
Executive deck (optional dashboard) and leadership readout with recommendations
Deliver and align
COMMERCIAL TERMS
Request a Commercial Proposal
Pricing depends on cohort, geography, sample size, approach, LOI, and deliverables. Configure below for an indicative estimate.
Select Sample Size
Geography
Select Mode of Survey
Length of the Interview
$0.00
+ applicable taxes
Cost Breakdown
Note: Estimate is indicative only. Final pricing is subject to scope finalization after discovery call.
REFERENCE CASELETS
Reference
Real-world examples of survey work in the B2B pharmaceutical research space.
Physician message recall & detailing channel preference (India)
OBJECTIVE
WHAT WE DID
DELIVERED
Physician message recall & detailing channel preference (India)
Hospital formulary inclusion barriers & KOL influence mapping (West India)
Physician message recall & detailing channel preference (India)
OBJECTIVE
A mid-size specialty pharma company needed to quantify how General Practitioners and Cardiologists ranked competing brands on message recall and detailing frequency , and whether recall scores predicted formulary consideration at the point of prescribing.
WHAT WE DID
Ran a structured quant survey across 320 physicians in 6 metros, capturing unaided brand recall , MR visit frequency , channel of last brand exposure , and time-to-prescription from first recall event to confirmed prescribing behaviour.
DELIVERED
A recall-to-prescription correlation matrix by specialty, a ranked detailing channel effectiveness map , and a message territory framework identifying which brand claims drove the strongest unaided recall among high-frequency prescribers.
FREQUENTLY ASKED QUESTIONS
Common Questions
Answers to frequently asked questions about this survey mandate.
What decisions will this survey enable?
Who is the buyer vs who are the respondents?
Can we see differences between primary care physicians, specialist consultants and hospital-based prescribers?
How will you measure prescription intent beyond simple brand awareness ratings?
Will the survey map the full prescribing decision journey and drop-offs?
Can this survey inform product and pricing strategy?
How will findings improve our medical representative detailing effectiveness?
Still have questions?
Schedule a discovery call to discuss your specific needs and get a custom quote.